nodes	percent_of_prediction	percent_of_DWPC	metapath
Bedaquiline—CYP3A4—Cytarabine—lymphatic system cancer	0.232	0.318	CbGbCtD
Bedaquiline—CYP3A4—Teniposide—lymphatic system cancer	0.229	0.313	CbGbCtD
Bedaquiline—CYP3A4—Mitoxantrone—lymphatic system cancer	0.16	0.219	CbGbCtD
Bedaquiline—CYP3A4—Vincristine—lymphatic system cancer	0.11	0.151	CbGbCtD
Bedaquiline—Septic shock—Vincristine—lymphatic system cancer	0.0166	0.062	CcSEcCtD
Bedaquiline—Hepatic cirrhosis—Methotrexate—lymphatic system cancer	0.0127	0.0474	CcSEcCtD
Bedaquiline—Haemoptysis—Fludarabine—lymphatic system cancer	0.0111	0.0414	CcSEcCtD
Bedaquiline—Transaminases increased—Carmustine—lymphatic system cancer	0.00865	0.0322	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Teniposide—lymphatic system cancer	0.00777	0.0289	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Fludarabine—lymphatic system cancer	0.00609	0.0227	CcSEcCtD
Bedaquiline—Hepatic enzyme increased—Mitoxantrone—lymphatic system cancer	0.00517	0.0193	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.00447	0.0166	CcSEcCtD
Bedaquiline—Anorexia—Mechlorethamine—lymphatic system cancer	0.00432	0.0161	CcSEcCtD
Bedaquiline—Arrhythmia—Teniposide—lymphatic system cancer	0.0042	0.0156	CcSEcCtD
Bedaquiline—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00394	0.0147	CcSEcCtD
Bedaquiline—Arrhythmia—Fludarabine—lymphatic system cancer	0.00369	0.0137	CcSEcCtD
Bedaquiline—Chest pain—Teniposide—lymphatic system cancer	0.00348	0.013	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.00328	0.0122	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.0032	0.0119	CcSEcCtD
Bedaquiline—Anorexia—Teniposide—lymphatic system cancer	0.00318	0.0119	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00313	0.0117	CcSEcCtD
Bedaquiline—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0031	0.0115	CcSEcCtD
Bedaquiline—Arthralgia—Fludarabine—lymphatic system cancer	0.00306	0.0114	CcSEcCtD
Bedaquiline—Myalgia—Fludarabine—lymphatic system cancer	0.00306	0.0114	CcSEcCtD
Bedaquiline—Decreased appetite—Teniposide—lymphatic system cancer	0.0029	0.0108	CcSEcCtD
Bedaquiline—Vomiting—Mechlorethamine—lymphatic system cancer	0.00288	0.0107	CcSEcCtD
Bedaquiline—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00288	0.0107	CcSEcCtD
Bedaquiline—Rash—Mechlorethamine—lymphatic system cancer	0.00286	0.0106	CcSEcCtD
Bedaquiline—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00285	0.0106	CcSEcCtD
Bedaquiline—Anorexia—Fludarabine—lymphatic system cancer	0.0028	0.0104	CcSEcCtD
Bedaquiline—Nausea—Mechlorethamine—lymphatic system cancer	0.00269	0.01	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00267	0.00996	CcSEcCtD
Bedaquiline—Connective tissue disorder—Carmustine—lymphatic system cancer	0.0026	0.00967	CcSEcCtD
Bedaquiline—Hepatic enzyme increased—Methotrexate—lymphatic system cancer	0.00258	0.0096	CcSEcCtD
Bedaquiline—Decreased appetite—Fludarabine—lymphatic system cancer	0.00255	0.0095	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00253	0.00943	CcSEcCtD
Bedaquiline—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00248	0.00923	CcSEcCtD
Bedaquiline—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00246	0.00915	CcSEcCtD
Bedaquiline—Arrhythmia—Carmustine—lymphatic system cancer	0.00236	0.00879	CcSEcCtD
Bedaquiline—Cardiac disorder—Vincristine—lymphatic system cancer	0.00234	0.00872	CcSEcCtD
Bedaquiline—Diarrhoea—Teniposide—lymphatic system cancer	0.00228	0.00851	CcSEcCtD
Bedaquiline—Myalgia—Bleomycin—lymphatic system cancer	0.00224	0.00836	CcSEcCtD
Bedaquiline—Chest pain—Bleomycin—lymphatic system cancer	0.00224	0.00836	CcSEcCtD
Bedaquiline—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.0022	0.00818	CcSEcCtD
Bedaquiline—Vomiting—Teniposide—lymphatic system cancer	0.00212	0.00791	CcSEcCtD
Bedaquiline—Rash—Teniposide—lymphatic system cancer	0.00211	0.00784	CcSEcCtD
Bedaquiline—Dermatitis—Teniposide—lymphatic system cancer	0.0021	0.00783	CcSEcCtD
Bedaquiline—Headache—Teniposide—lymphatic system cancer	0.00209	0.00779	CcSEcCtD
Bedaquiline—Anorexia—Bleomycin—lymphatic system cancer	0.00205	0.00764	CcSEcCtD
Bedaquiline—Diarrhoea—Fludarabine—lymphatic system cancer	0.00201	0.00748	CcSEcCtD
Bedaquiline—Nausea—Teniposide—lymphatic system cancer	0.00198	0.00739	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00196	0.0073	CcSEcCtD
Bedaquiline—Chest pain—Carmustine—lymphatic system cancer	0.00196	0.0073	CcSEcCtD
Bedaquiline—Myalgia—Carmustine—lymphatic system cancer	0.00196	0.0073	CcSEcCtD
Bedaquiline—Decreased appetite—Bleomycin—lymphatic system cancer	0.00187	0.00696	CcSEcCtD
Bedaquiline—Myalgia—Vincristine—lymphatic system cancer	0.00187	0.00696	CcSEcCtD
Bedaquiline—Vomiting—Fludarabine—lymphatic system cancer	0.00187	0.00695	CcSEcCtD
Bedaquiline—Rash—Fludarabine—lymphatic system cancer	0.00185	0.00689	CcSEcCtD
Bedaquiline—Dermatitis—Fludarabine—lymphatic system cancer	0.00185	0.00688	CcSEcCtD
Bedaquiline—Headache—Fludarabine—lymphatic system cancer	0.00184	0.00685	CcSEcCtD
Bedaquiline—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00182	0.00678	CcSEcCtD
Bedaquiline—Chest pain—Mitoxantrone—lymphatic system cancer	0.00182	0.00678	CcSEcCtD
Bedaquiline—Myalgia—Mitoxantrone—lymphatic system cancer	0.00182	0.00678	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00181	0.00673	CcSEcCtD
Bedaquiline—Anorexia—Carmustine—lymphatic system cancer	0.00179	0.00667	CcSEcCtD
Bedaquiline—Nervous system disorder—Vincristine—lymphatic system cancer	0.00176	0.00655	CcSEcCtD
Bedaquiline—Nausea—Fludarabine—lymphatic system cancer	0.00174	0.00649	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00171	0.00637	CcSEcCtD
Bedaquiline—Anorexia—Vincristine—lymphatic system cancer	0.00171	0.00636	CcSEcCtD
Bedaquiline—Anorexia—Mitoxantrone—lymphatic system cancer	0.00166	0.0062	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00163	0.00608	CcSEcCtD
Bedaquiline—Decreased appetite—Carmustine—lymphatic system cancer	0.00163	0.00608	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00162	0.00604	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00159	0.00592	CcSEcCtD
Bedaquiline—Decreased appetite—Vincristine—lymphatic system cancer	0.00156	0.0058	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00155	0.00576	CcSEcCtD
Bedaquiline—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00152	0.00565	CcSEcCtD
Bedaquiline—Vomiting—Bleomycin—lymphatic system cancer	0.00137	0.00509	CcSEcCtD
Bedaquiline—Rash—Bleomycin—lymphatic system cancer	0.00136	0.00505	CcSEcCtD
Bedaquiline—Dermatitis—Bleomycin—lymphatic system cancer	0.00136	0.00505	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00129	0.0048	CcSEcCtD
Bedaquiline—Diarrhoea—Carmustine—lymphatic system cancer	0.00129	0.00479	CcSEcCtD
Bedaquiline—Nausea—Bleomycin—lymphatic system cancer	0.00128	0.00476	CcSEcCtD
Bedaquiline—Dizziness—Carmustine—lymphatic system cancer	0.00124	0.00462	CcSEcCtD
Bedaquiline—Diarrhoea—Vincristine—lymphatic system cancer	0.00123	0.00457	CcSEcCtD
Bedaquiline—Hepatitis—Methotrexate—lymphatic system cancer	0.00122	0.00456	CcSEcCtD
Bedaquiline—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00119	0.00445	CcSEcCtD
Bedaquiline—Vomiting—Carmustine—lymphatic system cancer	0.00119	0.00445	CcSEcCtD
Bedaquiline—Dizziness—Vincristine—lymphatic system cancer	0.00119	0.00441	CcSEcCtD
Bedaquiline—Rash—Carmustine—lymphatic system cancer	0.00118	0.00441	CcSEcCtD
Bedaquiline—Dermatitis—Carmustine—lymphatic system cancer	0.00118	0.00441	CcSEcCtD
Bedaquiline—Headache—Carmustine—lymphatic system cancer	0.00118	0.00438	CcSEcCtD
Bedaquiline—Vomiting—Vincristine—lymphatic system cancer	0.00114	0.00424	CcSEcCtD
Bedaquiline—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00114	0.00423	CcSEcCtD
Bedaquiline—Rash—Vincristine—lymphatic system cancer	0.00113	0.00421	CcSEcCtD
Bedaquiline—Dermatitis—Vincristine—lymphatic system cancer	0.00113	0.00421	CcSEcCtD
Bedaquiline—Headache—Vincristine—lymphatic system cancer	0.00112	0.00418	CcSEcCtD
Bedaquiline—Nausea—Carmustine—lymphatic system cancer	0.00112	0.00415	CcSEcCtD
Bedaquiline—Vomiting—Mitoxantrone—lymphatic system cancer	0.00111	0.00413	CcSEcCtD
Bedaquiline—Rash—Mitoxantrone—lymphatic system cancer	0.0011	0.0041	CcSEcCtD
Bedaquiline—Dermatitis—Mitoxantrone—lymphatic system cancer	0.0011	0.0041	CcSEcCtD
Bedaquiline—Headache—Mitoxantrone—lymphatic system cancer	0.00109	0.00407	CcSEcCtD
Bedaquiline—Nausea—Vincristine—lymphatic system cancer	0.00106	0.00397	CcSEcCtD
Bedaquiline—Nausea—Mitoxantrone—lymphatic system cancer	0.00104	0.00386	CcSEcCtD
Bedaquiline—Chest pain—Methotrexate—lymphatic system cancer	0.000907	0.00338	CcSEcCtD
Bedaquiline—Myalgia—Methotrexate—lymphatic system cancer	0.000907	0.00338	CcSEcCtD
Bedaquiline—Arthralgia—Methotrexate—lymphatic system cancer	0.000907	0.00338	CcSEcCtD
Bedaquiline—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000853	0.00318	CcSEcCtD
Bedaquiline—Anorexia—Methotrexate—lymphatic system cancer	0.000829	0.00309	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000793	0.00295	CcSEcCtD
Bedaquiline—Decreased appetite—Methotrexate—lymphatic system cancer	0.000756	0.00282	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000751	0.0028	CcSEcCtD
Bedaquiline—Diarrhoea—Methotrexate—lymphatic system cancer	0.000595	0.00222	CcSEcCtD
Bedaquiline—Dizziness—Methotrexate—lymphatic system cancer	0.000575	0.00214	CcSEcCtD
Bedaquiline—Vomiting—Methotrexate—lymphatic system cancer	0.000553	0.00206	CcSEcCtD
Bedaquiline—Rash—Methotrexate—lymphatic system cancer	0.000549	0.00204	CcSEcCtD
Bedaquiline—Dermatitis—Methotrexate—lymphatic system cancer	0.000548	0.00204	CcSEcCtD
Bedaquiline—Headache—Methotrexate—lymphatic system cancer	0.000545	0.00203	CcSEcCtD
Bedaquiline—Nausea—Methotrexate—lymphatic system cancer	0.000517	0.00192	CcSEcCtD
